Skip to content

Ceruletide

VARIOUS

Also known as: caerulein, caerulein compd. with N-ethylethanamine, caerulein diethylamine salt, ceruletide diethylamine

FDA approvedATC V04CC04

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Ceruletide is a drug catalogued in DrugCentral. DrugCentral lists 1 molecular target, including CCKAR. Recorded indications include Diagnostic aid.

  • Molecular targets: CCKAR (1 listed in DrugCentral).
  • Indications: Diagnostic aid.
  • ATC code: V04CC04 (Tests for bile duct patency).
  • Molecular formula: C58H73N13O21S2; molecular weight 1352.43 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

  • Diagnostic aid

Mechanism & targets

Molecular targets (1)

TargetGeneActionActivity
Cholecystokinin receptor type ACCKARagonist—

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
—FDA—PHARMACIA AND UPJOHN

ATC classification

ATC codeTherapeutic hierarchy
V04CC04VARIOUS › DIAGNOSTIC AGENTS › OTHER DIAGNOSTIC AGENTS › Tests for bile duct patency

Chemical structure

Molecular formulaC58H73N13O21S2
Molecular weight1352.43 g/mol
CAS number—
InChIKeyYRALAIOMGQZKOW-HYAOXDFASA-N
PubChem CID16129675
CSCC[C@H](NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC1=CC=C(OS(O)(=O)=O)C=C1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCC(=O)N1)[C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(N)=O

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Ceruletide used for?

DrugCentral lists the following indications for Ceruletide: Diagnostic aid.

How does Ceruletide work?

Its molecular targets in DrugCentral include CCKAR (agonist).

What is the chemical formula of Ceruletide?

Ceruletide has the molecular formula C58H73N13O21S2 and a molecular weight of 1352.43 g/mol.

Browse: all drugs starting with C · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval—
AgencyFDA
Targets1
Indications1
FormulaC58H73N13O21S2
DrugCentral ID579
Interactive profile